Status:
UNKNOWN
Development of King's College Hospital Breathlessness Service
Lead Sponsor:
King's College London
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
King's College Hospital NHS Trust
Conditions:
Breathless Patients With Any Established Underlying Medical Diagnosis
Eligibility:
All Genders
16-90 years
Phase:
PHASE3
Brief Summary
Breathlessness is a common, distressing symptom in advanced malignant and non malignant disease, and impacts significantly on quality of life. Breathlessness in end stage disease is also responsible f...
Eligibility Criteria
Inclusion
- Patients with any established underlying medical diagnosis with breathlessness on exertion or at rest.
- Cancer patients who have risk factors for breathlessness( risk factors include a history of smoking, asthma or COPD, lung irradiation, exposure to asbestos, coal dust, cotton dust or grain dust, lung involvement by cancer)
- Respiratory muscle weakness
- Anxiety.
- Patients must have advanced disease that is refractory to maximal optimised medical management. - Patients must be able to engage with a short term physiotherapy and occupational therapy intervention.
Exclusion
- Patients with breathlessness of unknown cause.
- Chronic hyperventilation syndrome.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2013
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01165034
Start Date
July 1 2010
End Date
May 1 2013
Last Update
April 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College Hospital
London, London, United Kingdom, SE5 9JP